1AD - AdAlta Limited

[System]

AdAlta is a biotechnology company that is focused on developing its lead i-body drug candidate, AD-114, for the treatment of idiopathic pulmonary (lung) fibrosis (IPF) and other fibrotic diseases, for which current therapies have limited efficacy where there is a high-unmet medical need. The lead drug candidate AD-114 has shown both anti-fibrotic activity as well as anti-inflammatory activity in pre-clinical studies, which are important for the treatment and prevention of IPF.

It is anticipated that 1AD will list on the ASX during August 2016.

http://www.adalta.com.au

 

[finicky]

Tony Locantro pick, got into this a couple of days ago, just 30,000 @ 11c, was back at 10.5c next day but now I'd call the chart prospective. Saw the M.D interviewed via youtube, he seems ok.

 

[finicky]

Chart hit a 12 month high today. Presentation to biotech conference just out - good luck wading through that, I'm just paddling in the shallows thanks to a Tony Locantro tip.

 

[finicky]

Looks more like it means it this time. Can't comment on the science, too abstract for me - a chart and advice based hold.

Daily

 

[finicky]

Highest close in one and a half years today. One that will take patience as phase one trial progresses, going by comments of m.d five months ago (vid)

Daily

 

[finicky]

This should speed things up? Big spike in s.p this a.m, now settling in around prior short term peak. Could have sold half for a free carry if awake to it early enough. Probably wouldn't have been of a mind too anyway ?

 

[finicky]

Gapped down. Sold today @ 0.115. Recovered costs.
Trial disappointment for intravenous drug delivery, drug gets cleared by the liver, doesn't get to lungs, they're switching to inhalation delivery. Not following the science and my chart based reason for a buy evaporated some time ago. Market too dicey to hold something like this with patience at my level of understanding.

Daily

 

[frugal.rock]

A quick chart.

 

[finicky]

1AD chart looks prospective to me. Don't follow the fundamentals.

Some strange volume entering minnow biotechs that I haven't been noticing. Even Chimeric (CHM) where I'm down 77% on a small stake. And Nyrada (NYR) ! - explosive volume and price. Radiopharm (RAD) hasn't moved though. What gives? Could the sector be resonating to Dimerix's (DXB) progress? Or just traders ramping it all. Just been alerted by a podcast featuring T Locantro, he's swelling up with confidence like a cane toad under a lawn sprinkler.

Not Held
Not Buying

MONTHLY ALL DATA